ISPOR Europe panel: How do we attain sustainability, affordability and availability of CAR T therapies?
Amanda Whittal
November 2023
This ISPOR Europe panel explored the evolving landscape of CAR T therapies, their high potential for lifelong benefits, and the economic and logistical hurdles they face. From complex manufacturing to unique pricing and reimbursement challenges, CAR T therapies require novel approaches and collaborative policy actions to ensure affordability and accessibility.
The discussion looked at how shaping policy could support these life-changing treatments, highlighting the challenges and implications.
Panel
- Anne Kerber (BMS)
- Konstantinos Lykopoulos (Kite / Gilead)
- Tarang Sharma (World Health Organization Regional Office for Europe)
Moderator
- Amanda Whittal (Dolon)
